8-K
filed March 16, 2026, 7:59 PM ET
ticker RFL
CIK 0001713863
earnings
confidence high
sentiment neutral
materiality 0.60
Rafael Holdings Q2 net loss $6.4M; Phase 3 trial on track for Q3 2026 top-line
Rafael Holdings, Inc.
2026-Q2 EPS reported
-$0.32
revenue$451,000
- Net loss of $6.4M ($0.13 per share) vs $4.6M ($0.19) YoY; increase due to Cyclo consolidation.
- Cash and cash equivalents $37.8M as of Jan 31, 2026.
- R&D expenses $4.5M (up from $0.9M YoY) driven by Cyclo acquisition and Phase 3 trial costs.
- Phase 3 TransportNPC study of Trappsol Cyclo continued after DMC review; top-line results expected Q3 calendar 2026.
- G&A expenses $2.3M, down from $2.6M YoY, offset by Cyclo costs and lower payroll.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Rafael Holdings, Inc. reported the six months ended January 31, 2026 results: net income $16.2 million, EPS $0.32 per share.
- Period
- the six months ended January 31, 2026
- Net income
- $16.2 million
- EPS
- $0.32 per share
- Result
- reported results
Exact text from the filing
For the six months ended January 31, 2026, we recorded a net loss attributable to Rafael Holdings of $16.2 million, or $0.32 per share
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Rafael Holdings, Inc. reported the three months ended January 31, 2026 results: net income $6.4 million, EPS $0.13 per share.
- Period
- the three months ended January 31, 2026
- Net income
- $6.4 million
- EPS
- $0.13 per share
- Result
- reported results
Exact text from the filing
For the three months ended January 31, 2026, we recorded a net loss attributable to Rafael Holdings of $6.4 million, or $0.13 per share
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.